Journal of Brain and Neurology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Brain and Neurology (2025) Volume 8, Issue 1

Neurotransmitters: Chemical pathways of thought and emotion

Neurotransmitters: The chemical messengers of the brain*

Department of Pharmacology, Hebei Medical University, China

*Corresponding Author:
Souvik Ghosh
Department of Pharmacology
Hebei Medical University
China
E-mail: : Perroud12@gmail.com

Received: 02-Feb-2025, Manuscript No. AAJBN-25-169550; Editor assigned: 03-Feb-2025, PreQC No. AAJBN-25-169550(PQ); Reviewed: 16-Feb-2025, QC No. AAJBN-25-169550; Revised: 20-Feb-2025, Manuscript No. AAJBN-25-169550(R); Published: 27-Feb-2025, DOI:10.35841/aajbn-8.1.188

Citation Weslman J. Neurotransmitters: The chemical messengers of the brain. J Brain Neurol. 2025;8(1):188

Visit for more related articles at Journal of Brain and Neurology

Introduction

Neurotransmitters are specialized chemical substances that play a crucial role in transmitting signals between nerve cells, or neurons, within the brain and throughout the nervous system. These chemicals are essential for brain function, as they facilitate communication between neurons by crossing the tiny gap known as the synaptic cleft. Without neurotransmitters, the brain would be unable to process information, control body movements, or regulate emotions and behavior. Understanding neurotransmitters provides valuable insights into both normal brain function and the mechanisms underlying various neurological and psychiatric disorders. [1].

The process of neurotransmission begins when an electrical signal, or action potential, travels along the axon of a neuron toward its synaptic terminal. Upon arrival, this electrical impulse triggers the release of neurotransmitter molecules stored in synaptic vesicles. These molecules then diffuse across the synaptic cleft and bind to specific receptor sites on the membrane of the next neuron, transmitting the signal forward. This precise and rapid process ensures seamless communication in the nervous system, enabling everything from reflexes to complex thought processes. [2].

Neurotransmitters can be broadly categorized into excitatory and inhibitory types. Excitatory neurotransmitters, such as glutamate, increase the likelihood that the receiving neuron will fire an action potential, thereby amplifying neural activity. In contrast, inhibitory neurotransmitters, such as gamma-aminobutyric acid (GABA), decrease the likelihood of neuronal firing, providing balance and preventing overstimulation. This equilibrium between excitation and inhibition is essential for maintaining healthy brain function and preventing conditions such as seizures or anxiety disorders. Advances in neuroimaging and molecular biology have allowed scientists to study neurotransmitter systems in unprecedented detail. These developments hold promise for creating more effective, personalized treatments for disorders involving neurotransmitter imbalances. As research continues, our understanding of these chemical messengers will deepen, opening new pathways for improving mental health and cognitive performance [3].

Some of the most well-known neurotransmitters include dopamine, serotonin, acetylcholine, and norepinephrine. Dopamine is often associated with reward, pleasure, and motor control, playing a significant role in motivation and movement regulation. Serotonin is involved in mood regulation, sleep, and appetite, while acetylcholine is critical for learning, memory, and muscle activation. Norepinephrine is linked to alertness, attention, and the body’s stress response. Each neurotransmitter has specific pathways and functions, and imbalances can lead to various neurological or psychological conditions. Beyond medical research, neurotransmitter studies have also illuminated the connection between brain chemistry and everyday behavior. Stress, diet, exercise, and sleep can all influence neurotransmitter levels, affecting mood, cognition, and overall mental well-being. This understanding has inspired holistic approaches to brain health, emphasizing lifestyle factors alongside medical interventions [4].

Neurotransmitter activity is not only determined by their release but also by their removal from the synaptic cleft. This can occur through reuptake, where neurotransmitters are taken back into the presynaptic neuron, or through enzymatic breakdown. Many medications, such as antidepressants, work by influencing these processes. For example, selective serotonin reuptake inhibitors (SSRIs) increase serotonin availability by blocking its reuptake, thereby improving mood and alleviating depression symptoms. Research into neurotransmitters has revealed their role in numerous disorders, including Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, and epilepsy. For instance, Parkinson’s disease is linked to dopamine deficiency in specific brain regions, while Alzheimer’s disease is associated with reduced acetylcholine levels. Targeting neurotransmitter systems has therefore become a central strategy in the development of treatments for neurological and psychiatric illnesses. [5].

Conclusion

Neurotransmitters are the brain’s indispensable chemical messengers, orchestrating everything from thought and movement to emotion and memory. Their precise functioning ensures the brain’s ability to process information and respond appropriately to the environment. Disruptions in neurotransmitter systems can have profound effects, leading to neurological and psychiatric disorders. Ongoing research offers hope for better understanding, prevention, and treatment of such conditions, highlighting the importance of these remarkable molecules in maintaining brain health and overall quality of life.

References


  1. Shinnar S, Glauser TA.Febrile seizures.J Child Neur. 2002;44-52.
  2. Indexed atGoogle ScholarCross Ref

  3. Silverman IE, Restrepo L.Poststroke seizures.. Arc Neur. 2002;59(2):195-201.
  4. Google Scholar

  5. Litt B, Echauz J.Prediction of epileptic seizures.The Lan Neur. 2002;1(1):22-30.
  6. Indexed atGoogle Scholar

  7. Patel N, Ram D, Swiderska NFebrile seizures.2015;1(2):23-30.
  8. Indexed atGoogle ScholarCross Ref

  9. Delanty NMedical causes of seizures.The Lancet. 1998;352(9125):383-90.
  10. Indexed atGoogle ScholarCross Ref

Get the App